AAD 2026Abstract 72079
Efficacy, Safety and Tolerability of Sofpironium Gel, 12.45% in Adolescents and Young Adults with Primary Axillary Hyperhidrosis
Subgroup Analysis from Two Pivotal Phase 3 Trials
Cartwright M, Browning J, Hebert A, Lain T, Walker P
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Pediatric dermatology
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.791 · Not in PubMed: details from Crossref